Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-26 @ 2:35 AM
Study NCT ID:
NCT04652102
Status:
COMPLETED
Last Update Posted:
2024-04-29
First Post:
2020-12-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older
Sponsor:
CureVac
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-10
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-01
First Submit QC Date:
None
Study First Post Date:
2020-12-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-12-09
Results First Submit QC Date:
None
Results First Post Date:
2024-04-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-20
Last Update Post Date:
2024-04-29
Last Update Post Date Type:
ACTUAL